George Abercrombie

George Abercrombie

Director/Board Member at BIOCRYST PHARMACEUTICALS, INC.

Net worth: 150 424 $ as of 2024-03-30

69 year
Health Technology
Consumer Services
Commercial Services

Profile

George B.
Abercrombie
is currently an Independent Director at BioCryst Pharmaceuticals, Inc. and a Director at Physicians Interactive Holdings LLC.
He is also a Director at the North Carolina Glaxosmithkline Foundation, Hessian Pharmaceuticals, Inc., and the North Carolina Board of Science & Technology.
Additionally, he serves as an Adjunct Professor at The Fuqua School of Business.
In his former positions, Abercrombie served as the President & CEO-Pharmaceuticals Operations at Roche Holding AG.
He was also the President & Chief Executive Officer at Hoffmann-La Roche, Inc. from 2001 to 2009.
Abercrombie held the position of President & Chief Executive Officer at Roche Laboratories, Inc. and Vice Chairman at Project HOPE-The-People-To-People Health Foundation, Inc. He has also served as a Director at Vical, Inc., Inspire Pharmaceuticals, Inc., DemeRx, Inc., Brickell Subsidiary, Inc., OCERA Therapeutics LLC, Alaunos Therapeutics, Inc., Pharmaceutical Research & Manufacturers of America, Aptus Health, Inc., Tranzyme Pharma, Inc. (Canada), Johns Hopkins Bloomberg School of Public Health, Fresh Tracks Therapeutics, Inc., and Merck & Co., Inc. Abercrombie was the Chief Commercial Officer & Senior Vice President at Innoviva, Inc. from 2014 to 2018 and the Senior Vice President-US Commercial Operations at Glaxo Wellcome, Inc. from 1993 to 2001.
Abercrombie holds an MBA from Harvard University and an undergraduate degree from The University of North Carolina at Chapel Hill.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-06-12 29,611 ( 0.01% ) 150 424 $ 2024-03-30

George Abercrombie active positions

CompaniesPositionStart
BIOCRYST PHARMACEUTICALS, INC. Director/Board Member 2017-05-23
North Carolina Board of Science & Technology Corporate Officer/Principal -
Hessian Pharmaceuticals, Inc. Director/Board Member -
North Carolina Glaxosmithkline Foundation Director/Board Member -
Director/Board Member 2013-09-23
The Fuqua School of Business Corporate Officer/Principal -
All active positions of George Abercrombie

Former positions of George Abercrombie

CompaniesPositionEnd
FRESH TRACKS THERAPEUTICS, INC. Director/Board Member 2020-05-26
INNOVIVA, INC. Corporate Officer/Principal 2018-09-25
OCERA THERAPEUTICS INC Director/Board Member 2013-11-10
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of George Abercrombie's experience

Training of George Abercrombie

Harvard University Masters Business Admin
The University of North Carolina at Chapel Hill Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of George Abercrombie's experience

Connections

100 +

1st degree connections

26

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies6
BIOCRYST PHARMACEUTICALS, INC.

Health Technology

MERCK & CO., INC.

Health Technology

ROCHE HOLDING AG

Health Technology

INNOVIVA, INC.

Health Technology

ALAUNOS THERAPEUTICS, INC.

Health Technology

FRESH TRACKS THERAPEUTICS, INC.

Health Technology

Private companies16

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Distribution Services

Glaxo Wellcome, Inc.

Health Technology

Commercial Services

Tranzyme Pharma, Inc. (Canada)

North Carolina Board of Science & Technology

Commercial Services

North Carolina Glaxosmithkline Foundation

Hessian Pharmaceuticals, Inc.

See company connections
  1. Stock Market
  2. Insiders
  3. George Abercrombie